Freestone Capital Holdings LLC Has $1.38 Million Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Freestone Capital Holdings LLC reduced its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 12.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 2,313 shares of the biotechnology company’s stock after selling 317 shares during the period. Freestone Capital Holdings LLC’s holdings in Axon Enterprise were worth $1,375,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in the business. New Wave Wealth Advisors LLC bought a new position in Axon Enterprise during the fourth quarter worth $40,000. Y.D. More Investments Ltd bought a new stake in shares of Axon Enterprise during the fourth quarter worth about $45,000. Prestige Wealth Management Group LLC grew its holdings in shares of Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares during the last quarter. Stonebridge Financial Group LLC bought a new stake in Axon Enterprise in the fourth quarter valued at approximately $53,000. Finally, GPS Wealth Strategies Group LLC lifted its stake in Axon Enterprise by 74.1% in the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock valued at $56,000 after buying an additional 40 shares during the period. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Price Performance

NASDAQ:AXON opened at $499.31 on Friday. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The stock has a 50 day moving average of $603.60 and a two-hundred day moving average of $527.57. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm has a market cap of $38.07 billion, a P/E ratio of 129.02, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12.

Wall Street Analyst Weigh In

AXON has been the topic of a number of research reports. Craig Hallum lowered Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 target price on the stock. in a research report on Thursday, February 20th. JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Robert W. Baird boosted their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a research report on Wednesday, February 26th. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $587.38.

Insider Activity

In other news, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the sale, the director now directly owns 24,259 shares in the company, valued at $15,518,239.71. This represents a 3.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, President Joshua Isner sold 1,291 shares of the company’s stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total value of $829,377.13. Following the completion of the sale, the president now owns 181,892 shares of the company’s stock, valued at $116,852,877.56. This trade represents a 0.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 5,146 shares of company stock worth $3,262,847 over the last ninety days. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.